Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-27T11:07:18.274Z Has data issue: false hasContentIssue false

An economic analysis of the costs associated with weight status in chronic obstructive pulmonary disease (COPD)

Published online by Cambridge University Press:  27 January 2012

P. F. Collins
Affiliation:
Institute of Human Nutrition, School of Medicine, University of Southampton, Southampton, SO16 6YD, UK
R. J. Stratton
Affiliation:
Institute of Human Nutrition, School of Medicine, University of Southampton, Southampton, SO16 6YD, UK
M. Elia
Affiliation:
Institute of Human Nutrition, School of Medicine, University of Southampton, Southampton, SO16 6YD, UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2012

Malnutrition in patients with COPD is a common problem which has been associated with increased healthcare utilisation(Reference Collins, Stratton, Kurukulaaratchy and Elia1). In contrast, epidemiological studies have reported that obesity in COPD is associated with better survival than both underweight and normal weight COPD patients(Reference Vestbo, Prescott, Almdal, Dahl, Nordestgaard, Andersen, Sorensen and Lange2), contributing to the concept of the ‘obesity paradox’, The aim of this study is to examine the extent to which weight status, over a wide range of body mass index (BMI), influences healthcare costs in COPD.

424 outpatients with COPD were followed up for 1 year post screening during 2008–2009. BMI and healthcare use (emergency and elective hospital admissions, length of stay, outpatient appointments) were recorded. Healthcare costs were established according to Department of Health NHS reference costs 2007(3) and modelled according to BMI classification at the point of screening.

Fig. 1. Total secondary healthcare use costs per patient per year according to BMI, adjusted for age, gender and COPD disease-severity (GOLD 2009), using univariate analysis.

The figure shows that the lowest healthcare costs are associated with a BMI in the obesity range (BMI ~32 kg/m2), an increase in the BMI range of 20–25 kg/m2and as much as a 2 to 3-fold increase in the BMI range of <20 kg/m2. The increased costs associated with a BMI <25 kg/m2 were mainly attributed to increased frequency of emergency admissions. The costs increased in the severely obese (BMI>40 kg/m2) but were not as high as those who were underweight (BMI<20 kg/m2).

This study suggests that after adjusting for certain confounding variables including COPD severity (Fig. 1) the lowest costs were associated with obesity (BMI 30–35 kg/m2) and the highest with underweight (BMI<20 kg/m2). The optimal BMI for nutritional intervention in COPD remains to be established.

Acknowledgement: funded by an unrestricted educational grant from Nutricia Ltd.

References

1.Collins, PF, Stratton, RJ, Kurukulaaratchy, R & Elia, M (2010) Thorax 65, A73A74.CrossRefGoogle Scholar
2.Vestbo, J, Prescott, E, Almdal, T, Dahl, M, Nordestgaard, BG, Andersen, T, Sorensen, TI & Lange, P (2006) Am J Respir Crit Care Med 173, 7983.Google Scholar
3.Department of Health (2007) NHS reference costs 2007. www.doh.gov.ukGoogle Scholar
Figure 0

Fig. 1. Total secondary healthcare use costs per patient per year according to BMI, adjusted for age, gender and COPD disease-severity (GOLD 2009), using univariate analysis.